Float Short %

1.17

Margin Of Safety %

Put/Call OI Ratio

0.19

EPS Next Q Diff

EPS Last/This Y

-0.02

EPS This/Next Y

0.01

Price

2.63

Target Price

Analyst Recom

Performance Q

-13.87

Relative Volume

0.62

Beta

0.37

Ticker: ANIX

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-04-14	ANIX	2.62	0.15	100.00	2604
2025-04-15	ANIX	2.85	0.15	100.00	2604
2025-04-16	ANIX	2.74	0.11	999.99	2505
2025-04-17	ANIX	2.68	0.12	0.00	2535
2025-04-18	ANIX	2.72	0.12	0.00	2535
2025-04-21	ANIX	2.63	0.12	0.00	2535
2025-04-22	ANIX	2.73	0.20	0.00	790
2025-04-23	ANIX	2.79	0.20	0.00	790
2025-04-24	ANIX	2.7	0.19	0.75	813
2025-04-25	ANIX	2.76	0.19533527696793	0	820
2025-04-28	ANIX	2.8	0.19476744186047	0	822
2025-04-29	ANIX	2.82	0.19	0.00	822
2025-04-30	ANIX	2.84	0.19	0.00	822
2025-05-01	ANIX	2.82	0.19	0.00	822
2025-05-02	ANIX	2.79	0.19	0.00	824
2025-05-05	ANIX	2.81	0.19	0.00	824
2025-05-06	ANIX	2.64	0.19	0.00	824
2025-05-07	ANIX	2.6	0.19	0.00	824
2025-05-08	ANIX	2.62	0.19	0.00	824
2025-05-09	ANIX	2.63	0.19	0.00	829
2025-05-12	ANIX	2.64	0.19	0.00	829
2025-05-13	ANIX	2.68	0.19	0.00	829
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-04-14	ANIX	2.65	0.0	-	-0.41
2025-04-15	ANIX	2.85	0.0	-	-0.41
2025-04-16	ANIX	2.77	0.0	-	-0.41
2025-04-17	ANIX	2.72	0.0	-	-0.41
2025-04-18	ANIX	2.72	0.0	-	-0.41
2025-04-21	ANIX	2.63	0.0	-	-0.41
2025-04-22	ANIX	2.72	0.0	-	-0.41
2025-04-23	ANIX	2.73	0.0	-	-0.41
2025-04-24	ANIX	2.75	0.0	-	-0.41
2025-04-25	ANIX	2.76	0.0	-	-0.41
2025-04-28	ANIX	2.80	0.0	-	-0.41
2025-04-29	ANIX	2.75	0.0	-	-0.41
2025-04-30	ANIX	2.79	0.0	-	-0.41
2025-05-01	ANIX	2.79	0.0	-	-0.41
2025-05-02	ANIX	2.78	0.0	-	-0.41
2025-05-05	ANIX	2.79	0.0	-	-0.41
2025-05-06	ANIX	2.65	0.0	-	-0.41
2025-05-07	ANIX	2.60	0.0	-	-0.41
2025-05-08	ANIX	2.64	0.0	-	-0.41
2025-05-09	ANIX	2.62	0.0	-	-0.41
2025-05-12	ANIX	2.66	0.0	-	-0.41
2025-05-13	ANIX	2.63	0.0	-	-0.41
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-04-14	ANIX	4.82	4.65	1.26
2025-04-15	ANIX	4.82	4.65	1.26
2025-04-16	ANIX	4.82	4.65	1.26
2025-04-17	ANIX	4.82	4.65	1.26
2025-04-18	ANIX	4.82	4.65	1.26
2025-04-21	ANIX	4.82	4.94	1.26
2025-04-22	ANIX	4.82	4.94	1.26
2025-04-23	ANIX	4.82	4.94	1.26
2025-04-24	ANIX	4.82	4.94	1.26
2025-04-25	ANIX	4.82	4.94	1.26
2025-04-28	ANIX	4.82	5.43	1.21
2025-04-29	ANIX	4.82	5.43	1.21
2025-04-30	ANIX	4.82	5.43	1.21
2025-05-01	ANIX	4.82	5.43	1.21
2025-05-02	ANIX	4.82	5.43	1.21
2025-05-05	ANIX	4.82	4.27	1.21
2025-05-06	ANIX	4.82	4.27	1.21
2025-05-07	ANIX	4.82	4.27	1.21
2025-05-08	ANIX	4.82	4.27	1.21
2025-05-09	ANIX	4.82	4.27	1.21
2025-05-12	ANIX	4.82	4.30	1.17
2025-05-13	ANIX	4.82	4.30	1.17
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.1

Avg. EPS Est. Current Quarter

-0.1

Avg. EPS Est. Next Quarter

-0.1

Insider Transactions

4.82

Institutional Transactions

4.3

Beta

0.37

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

67.5

Max Drawdown 5-Year %

-70.2

Target Price

P/E

Forward P/E

PEG

P/S

P/B

4.82

P/Free Cash Flow

EPS

-0.39

Average EPS Est. Cur. Y

-0.41

EPS Next Y. (Est.)

-0.4

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.62

Return on Equity vs Sector %

-93.6

Return on Equity vs Industry %

-76.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Anixa Biosciences, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 5

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs include the development of a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company's vaccine programs include the development of a vaccine against breast cancer, initially focused on triple negative breast cancer (TNBC), the most lethal form of breast cancer; and the development of a vaccine against ovarian cancer, as well as a vaccine discovery program to develop additional cancer vaccines to address intractable cancers, including high incidence malignancies in lung, colon, and prostate. Its vaccine technologies focus on the discovery of additional retired proteins that may be associated with other forms of cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

stock quote shares ANIX – Anixa Biosciences Inc Stock Price stock today

news today ANIX – Anixa Biosciences Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch ANIX – Anixa Biosciences Inc yahoo finance google finance

stock history ANIX – Anixa Biosciences Inc invest stock market

stock prices ANIX premarket after hours

ticker ANIX fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ANIX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y